Recombinant Human Putative apoptosis inhibitor FKSG2 (FKSG2)

ACP10621

Number

Order Exclusive Products Now

Request a Quote

High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications

Cat.No	ACP10621	Target Name	TPT1P8
Target Synonyms	TPT1P8; FKSG2; Putative translationally-controlled tumor protein-like protein TPT1P8; Putative apoptosis inhibitor FKSG2	Form	Lyophilized powder
Expression System	Custom Production. Please inquire and provide the desire expression system.	Expression Range	1-139
Protein Length	Full length protein	Purity	>85% (SDS-PAGE)
Storage Buffer	5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information

Target Species	Human	Uniprot ID	Q9HAU6

Background Information

Uniprot Id

Q9HAU6
Target Species

Human
Target Name

TPT1P8
Target Full Name

Putative translationally-controlled tumor protein-like protein TPT1P8
Target Synonyms

TPT1P8; FKSG2; Putative translationally-controlled tumor protein-like protein TPT1P8; Putative apoptosis inhibitor FKSG2

Inquire Recombinant Human Putative apoptosis inhibitor FKSG2 (FKSG2) Now

Full Name *

Business Email Address *

Phone

Products/Services

Catalog Number

Quantity (μg, mg, g, μl, ml, L, kit)

Address

Project Description

AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Submit

Recombinant Human Putative apoptosis inhibitor FKSG2 (FKSG2)

Specifications

Immunogen Information

Inquire Recombinant Human Putative apoptosis inhibitor FKSG2 (FKSG2) Now

Related Products